ElizabethWLoderMD
Internal Medicine • Boston, MAChief of the Division of Headache and Pain in the Department of Neurology at Brigham and Women’s Hospital. Associate Professor of Neurology at Harvard Medical School. President of the American Headache Society.
Are you Dr. Loder?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
125 Nashua St
Boston, MA 02114Phone+1 615-573-2493Fax+1 617-573-7119
Summary
- Dr. Elizabeth Loder, MD is an internist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Brigham and Women's Hospital and Brigham and Women's Faulkner Hospital.
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 1985 - 1989
University of North Dakota School of Medicine and Health SciencesClass of 1985
Certifications & Licensure
MA State Medical License 1987 - 2025- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 38276 citationsThe PRISMA 2020 statement: an updated guideline for reporting systematic reviewsMatthew J. Page, Joanne E. McKenzie, Patrick M.M. Bossuyt, Isabelle Boutron, Tammy Hoffmann
BMJ. 2021-03-29 - 3899 citationsPRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.Matthew J. Page, David Moher, Patrick M.M. Bossuyt, Isabelle Boutron, Tammy Hoffmann
BMJ. 2021-03-29 - 5502 citationsThe International Classification of Headache Disorders, 3rd edition (beta version)Jes Olesen, André Bes, Robert S. Kunkel, James W. Lance, Giuseppe Nappi
Cephalalgia. 2013-07-01
Press Mentions
Beyond CGRP: New Monoclonal Antibody Class Shows Promise for MigraineSeptember 6th, 2024- Novel Agent Reduces Monthly Migraine DaysSeptember 4th, 2024
- Ubrogepant in Migraine Prodrome Helps Patients Return to Normal Function SoonerAugust 28th, 2024
- Join now to see all
